ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,807Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 49

$587K Total Retail Price of All Prescriptions

Rank: 5 out of 49

397 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wyoming
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 397 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 397 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 6,776 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wyoming
LEVOTHYROXINE SODIUM 338 310 1 1
SIMVASTATIN 332 310 2 2
ZOLPIDEM TARTRATE 290 226 3 19
AMLODIPINE BESYLATE 223 204 4 6
ATORVASTATIN CALCIUM 209 191 5 13
HYDROCODONE-ACETAMINOPHEN 161 146 S3 6 7
METOPROLOL SUCCINATE 141 126 7 16
CYMBALTA 136 100 8 33
OMEPRAZOLE 131 120 9 4
LISINOPRIL 130 117 10 3
FUROSEMIDE 124 122 11 5
ALLOPURINOL 123 111 12 21
LOSARTAN POTASSIUM 122 115 13 14
POTASSIUM CHLORIDE 117 106 14 9
WARFARIN SODIUM 105 96 15 8
CITALOPRAM HBR 105 101 15 18
TRIAMTERENE-HCTZ 100 99 17 43
FLUTICASONE PROPIONATE 98 90 18 51
POLYETHYLENE GLYCOL 3350 93 86 19 78
HYDROCHLOROTHIAZIDE 87 72 20 12
ESCITALOPRAM OXALATE 84 78 21 52
OXYCODONE-ACETAMINOPHEN 80 53 S2 22 111
GABAPENTIN 73 45 23 15
RAMIPRIL 70 61 24 79
SERTRALINE HCL 70 56 24 22
FENTANYL 69 57 S2 26 59
ATENOLOL 68 67 27 17
VENLAFAXINE HCL ER 68 57 27 80
ADVAIR DISKUS 65 53 29 28
PREDNISONE 63 61 30 30
MELOXICAM 60 48 31 31
PAROXETINE HCL 60 33 31 87
LYRICA 57 23 33 83
METFORMIN HCL 55 43 34 10
OXYCONTIN 53 13 S2 35 163
METOPROLOL TARTRATE 53 40 35 11
LOSARTAN-HYDROCHLOROTHIAZIDE 52 52 37 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 26, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.